Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
NEXIEN BIOPHARMA, INC. (NXEN) had Debt to Equity Ratio of -0.83 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.03M |
|
-- |
|
-- |
|
$0.01M |
|
$-0.01M |
|
$-0.02M |
|
$-0.03M |
|
$-0.03M |
|
$-0.03M |
|
$-0.03M |
|
$-0.03M |
|
$-0.03M |
|
$-0.01M |
|
$-0.01M |
|
70.77M |
|
70.77M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.01M |
|
-- |
|
-- |
|
$0.01M |
|
$0.46M |
|
-- |
|
-- |
|
$0.46M |
|
$-0.45M |
|
$-0.45M |
|
$-0.45M |
|
70.77M |
|
| Cash Flow Statement Financials | |
$-0.05M |
|
-- |
|
$0.06M |
|
$0.00M |
|
$0.01M |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-0.83 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
6.68% |
|
6.68% |
|
-363.21% |
|
6.68% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|